1 / 36

Prevention of OHSS

Prevention of OHSS. Dr. Hakan Özörnek EUROFERTIL IVF Center. OHSS. OHSS is an iatrogenic complication of ovulation induction . The syndrom can result in serious life treatening complications

sirvat
Download Presentation

Prevention of OHSS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Prevention of OHSS Dr. Hakan Özörnek EUROFERTIL IVF Center

  2. OHSS • OHSS is an iatrogeniccomplication of ovulationinduction. • Thesyndrom can result in serious life treateningcomplications • Thesyndromcharecterizedbyleakage of fluidfromtheintravascularcompartment, withaccumulation in theperitonealandpleuralcavities, resulting in hypotensionand a decrease in renalbloodflowandvolume of urine.

  3. Classification • Mild OHSS • Grade 1 Abdominaldistentionanddiscomfort • Grade 2 + nausea, vomitingand/ordiarrhoea • Moderate OHSS • Grade 3 + ultrasonicevidence of ascites • Severe OHSS • Grade 4 + clinicalevidence of ascitesand/orhydrothoraxordyspnoea • Grade 5 + haemoconcentration, coagulationabnormalities, diminishedrenalperfusion Golan et al. 1989

  4. Prevention of OHSS

  5. Risk factorsfor OHSS • PCOS • Highnumber of antralfollicles at day3 (>10/ovary) • Enlargedovarianvolume • LH/FSH > 2 • Hyperandrogenism • Youngage < 35 • Low body weight • Previousocurrence of OHSS

  6. Preventionby PCOS • Diet – weightlose • Metformin • Ovariandrilling • Nonstimulated – naturalcycle • IVM • Oral ovulationinduction • Lowdosegonadotropin

  7. Metformin Khattab, ReprodBiomed Online, 2006

  8. Metformin • In a systematicreviewfor IVF, it wasfoundthatmetforminledtofewercases of OHSS (RR 0.33;95% CI 0.13-0.80) Moll et al. 2007

  9. Prevention of OHSS • WithholdinghCG ‘cancelling’ • DelayinghCG ‘coasting’ • Modification of methodstotriggerovulation • Earlyunilateralfollicularaspiration • Progesteroneforlutealphasesupport • Cryopreservation of allembryos • GradualandslowhMGprotocol in PCOS • Albuminadministration at time of retrieval • Glucocorticoidadministration

  10. CancelingCycles • hCGtriggersthedevelopment of OHSS • WithholdinghCG is theonlymethodthattotallyavoidsthe risk of OHSS • Serum E2 levelupper limit 4000 pg/ml • AfterstoppingthegonadotrophintreatmenttheGnRHagonistor antagonist should be continiueduntiltheovariesrecoverto normal size

  11. Modification of methodstotriggerovulation • Decrease in hCGdose • 10.000 IU vs. 5.000 IU or 3.000 IU no difference • GnRHa • Used in antagonist cycle, as effective as hCG, decreasedinsidence of OHSS • rLH • PRT multicenterhCG vs rLHsignificantlyfewermoderateand severe cases of OHSS • rhCG

  12. 5000 vs. 10000 IU uHCG Tsoumpou I, RBM Online, 2009

  13. GnRHa • Thequickreversibility of the antagonist inducedpituitarysuppression can be of advantagebyallowingtheuse of GnRHaforthepurpose of ovulationtriggering. • A GnRHagonisttriggereffectivelyprevents OHSS.

  14. Folicularaspiration • Folicularaspiration at the time of oocyteretrieval had no protectiveeffect of OHSS • Unilateralfolicularaspirationpriorto HCG alsodoes not reducetheincidence of severe OHSS

  15. Glucocorticoidadministration • Because of conflictingreports in theliteraturetherearecurrentlyinsufficient data torecommendglucocorticoidadministration Lainas et al., Fertil Steril, 2002

  16. Luthealphasesupport • LuthealphasesupportwithhCGincreasestheincidence of OHSS. • Progesteroneintravaginallyor im should be usedforthepatients at risk of OHSS

  17. Antagonists Al-Inany HG, RBM Online, 2007

  18. Antagonists • In a Cochranerewievtherelativeodds of hospitaladmissionfor OHSS wasreducedbye 54 % withantagonistscomparedwithagonists. Kolibianakis EM, Hum ReprodUpdate, 2006

  19. Coasting • FirstdescribedandappliedbySher et al in 1993 • hCGadministrationpostponeduntilthepatients serum E2 leveldecreasesto a safer zone. • Significantlyhigherpercentage of granulosaluteincellsbecomeapoptoticaftercoasting. E2 levelsusuallytoriserapidly in the 48 h followinginitiation of thecoastingperiod, thenplateauedandbegantofall 96-168 h afterthegonadotropinswerestopped.

  20. Coasting • Cochranereviewidentified 13 studies of whichonlyonetrial met theinclusioncriteria. • Therewas no difference in theincidence of moderateand severe OHSS and in theclinicalpregnancy rate betweenthegroups. D’Angelo et al., CochraneLibrary, 2002

  21. Coastingstudies(Garcia-Velasco, F&S, 2006) 34/1624 0.02%

  22. Coastingduration Mansour, et al., Fertil Steril, 2005

  23. Coasting(Practicalguidelines) • Start at • Serum E2>4500 pg/ml • > 15 and < 30 maturefollicles • Measure E2 on a dailybasis, do not skipanydaytoavoidsuddenunexpecteddrops • GivehCGwhen E2 levelfallsto < 3500 pg/ml • Abandone if • E2 levelrisesto >6500 pg/ml • > 30 maturefollicles • Coastingtakes > 4 days

  24. Coasting • Coasting is a goodalternativethat can avoidcyclecancellation in highresponders, whohavehigh risk of developing severe OHSS • Evenif OHSS developsaftercoastingbothitsincidenceandseveritywill be diminished

  25. Cryopreservation of allembryos • Insted of cancelingthecycleaftertheadministration of hCGretrievetheoocytesandthancryopreserveallembryos • Cochranereviewidentified 17 studies, two of which met theinclusioncriteria. • Whenelectivecryopreservationwascomparedwithfreshembryo transfer no differencewasfoundbetweenthetwogroups in theincidence of OHSS. • There is insufficientevidencetosupportroutinecryopreservation. D’Angelo et al., CochraneLibrary, 2002

  26. Albuminadministration • Albumin is preventthedevelopment of OHSS byincreasingplasmaoncoticpressureandbinding of OHSS mediators of ovarianorigin • Thecochranereviewshows a clearbenefitfromadministration of iv albumin at te time of oocyteretrieval in prevention of severe OHSS in high risk cases. • Forevery 18 women at risk of severe OHSS albumininfusionwillsaveonemorecase • Albumin is a humanproduct! D’Angelo et al., CochraneLibrary, 2002

  27. HES (Hydroxyethylstarchsolution) administration • Syntheticmacromoleculesusedtoprevent OHSS andavoidthepotentialrisksfromusinghumanproductssuch as albumin • HES is effectivevolumeexpander. It is as effective as albumin • It is cheaperand safer

  28. Dopamineagonists • VEGF is directlyinvolved in theclinicalmanifestations of OHSS byincreasingvascularpermeability. • Dopamineagonistshavebeenshowntosignificantlyreducevascularpermeability. • Theadministration of dopamineagonists at dosesthatareroutinelyusedtotreathyperprolactinaemicpatients, can reducevascularpermeabilitydecreasingthe risk andseverity of OHSS

  29. DopamineAgonists • Dopamineagonistshave a positiveeffect on OHSS symptomssuch as ascites, abdominaldistensionanddiscomfort. • Fertilization, implantationandongoingpregnancyratesare not affectedbytheuse of dopamineagonistsduringassistedreproductiontreatments.

  30. Cabergoline • First RCT showedthatcabergolinesignificantlyloweredhaematocrit, haemoglobinandascites on day 4 andday 6 aftertreatment, as comparedwithplacebo. • 35 high risk OHSS patients • 0.5 mg Cabergolin start on HCG dayadministerfor 8 days • No OHSS, pregnancy rate 41% Alvarez et al, 2007

  31. Conclusion • OHSS is a seriouscomplication of ovarianstimulation • Theidentification of high risk patientsand in particular PCOS patientsandtheuse of lowdoseprotocols of ovarianstimulationhave an important role in theprevention of OHSS • Todate no methodsareavailabletocompletlypreventthiscomplicationexceptforwithholdinghCG.

  32. Conclusion • Coastingfor at least as long as 3 days can be successfullyused in theprevention of OHSS • Itappearsthat iv albuminadministered at the time of oocyteretrievalmayhelptheprevention of OHSS • Theeffect of combiningmethodswhichact at twodifferentlevels (eq. coastingand HES administration) helpsfor a betterprevention

  33. Conclusion • Cryopreservation of oocytes, use of GnRH antagonist andDopaminederivateswereusedsuccessfully. • There is a clearneedforlargerandomisedstudies

More Related